Literature DB >> 28486039

Flow cytometric measurement of the cellular propagation of TDP-43 aggregation.

Rafaa Zeineddine1,2, Daniel R Whiten1,2, Natalie E Farrawell1,2, Luke McAlary1,2, Maya A Hanspal3,4, Janet R Kumita3,4, Mark R Wilson1,2, Justin J Yerbury1,2.   

Abstract

Amyotrophic lateral sclerosis is a devastating neuromuscular degenerative disease characterized by a focal onset of motor neuron loss, followed by contiguous outward spreading of pathology including TAR DNA-binding protein of 43 kDa (TDP-43) aggregates. Previous work suggests that TDP-43 can move between cells. Here we used a novel flow cytometry technique (FloIT) to analyze TDP-43 inclusions and propagation. When cells were transfected to express either mutant G294A TDP-43 fused to GFP or wild type TDP-43fused to tomato red and then co-cultured, flow cytometry detected intact cells containing both fusion proteins and using FloIT detected an increase in the numbers of inclusions in lysates from cells expressing wild type TDP-43-tomato. Furthermore, in this same model, FloIT analyses detected inclusions containing both fusion proteins. These results imply the transfer of TDP-43 fusion proteins between cells and that this process can increase aggregation of wild-type TDP-43 by a mechanism involving co-aggregation with G294A TDP-43.

Entities:  

Keywords:  ALS; FloIT; Flow cytometry; Prion; Propagation; Protein Aggregation; TDP-43

Mesh:

Substances:

Year:  2017        PMID: 28486039      PMCID: PMC5480386          DOI: 10.1080/19336896.2017.1314426

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  25 in total

1.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

Review 2.  Protein aggregates stimulate macropinocytosis facilitating their propagation.

Authors:  Justin J Yerbury
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

3.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

4.  Prion-like properties of pathological TDP-43 aggregates from diseased brains.

Authors:  Takashi Nonaka; Masami Masuda-Suzukake; Tetsuaki Arai; Yoko Hasegawa; Hiroyasu Akatsu; Tomokazu Obi; Mari Yoshida; Shigeo Murayama; David M A Mann; Haruhiko Akiyama; Masato Hasegawa
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

5.  Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes.

Authors:  Maddalena Costanzo; Saïda Abounit; Ludovica Marzo; Anne Danckaert; Zeina Chamoun; Pascal Roux; Chiara Zurzolo
Journal:  J Cell Sci       Date:  2013-06-18       Impact factor: 5.285

6.  Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.

Authors:  E Buratti; F E Baralle
Journal:  J Biol Chem       Date:  2001-07-24       Impact factor: 5.157

7.  TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Jemeen Sreedharan; Ian P Blair; Vineeta B Tripathi; Xun Hu; Caroline Vance; Boris Rogelj; Steven Ackerley; Jennifer C Durnall; Kelly L Williams; Emanuele Buratti; Francisco Baralle; Jacqueline de Belleroche; J Douglas Mitchell; P Nigel Leigh; Ammar Al-Chalabi; Christopher C Miller; Garth Nicholson; Christopher E Shaw
Journal:  Science       Date:  2008-02-28       Impact factor: 47.728

8.  SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation.

Authors:  Rafaa Zeineddine; Jay F Pundavela; Lisa Corcoran; Elise M Stewart; Dzung Do-Ha; Monique Bax; Gilles Guillemin; Kara L Vine; Danny M Hatters; Heath Ecroyd; Christopher M Dobson; Bradley J Turner; Lezanne Ooi; Mark R Wilson; Neil R Cashman; Justin J Yerbury
Journal:  Mol Neurodegener       Date:  2015-10-31       Impact factor: 14.195

9.  TDP-43 is intercellularly transmitted across axon terminals.

Authors:  Marisa S Feiler; Benjamin Strobel; Axel Freischmidt; Anika M Helferich; Julia Kappel; Bryson M Brewer; Deyu Li; Dietmar R Thal; Paul Walther; Albert C Ludolph; Karin M Danzer; Jochen H Weishaupt
Journal:  J Cell Biol       Date:  2015-11-23       Impact factor: 10.539

10.  Rapid flow cytometric measurement of protein inclusions and nuclear trafficking.

Authors:  D R Whiten; R San Gil; L McAlary; J J Yerbury; H Ecroyd; M R Wilson
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379

View more
  13 in total

Review 1.  Mechanisms of TDP-43 Proteinopathy Onset and Propagation.

Authors:  Han-Jou Chen; Jacqueline C Mitchell
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

Review 2.  Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.

Authors:  Alistair Wood; Yuval Gurfinkel; Nicole Polain; Wesley Lamont; Sarah Lyn Rea
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 3.  Multi-phaseted problems of TDP-43 in selective neuronal vulnerability in ALS.

Authors:  Kazuhide Asakawa; Hiroshi Handa; Koichi Kawakami
Journal:  Cell Mol Life Sci       Date:  2021-03-11       Impact factor: 9.261

4.  Nucleo-cytoplasmic transport of TDP-43 studied in real time: impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons.

Authors:  Adam J Svahn; Emily K Don; Andrew P Badrock; Nicholas J Cole; Manuel B Graeber; Justin J Yerbury; Roger Chung; Marco Morsch
Journal:  Acta Neuropathol       Date:  2018-06-25       Impact factor: 17.088

5.  TDP-43 Is Efficiently Transferred Between Neuron-Like Cells in a Manner Enhanced by Preservation of Its N-Terminus but Independent of Extracellular Vesicles.

Authors:  Christopher Sackmann; Valerie Sackmann; Martin Hallbeck
Journal:  Front Neurosci       Date:  2020-06-11       Impact factor: 4.677

Review 6.  The Relevancy of Data Regarding the Metabolism of Iron to Our Understanding of Deregulated Mechanisms in ALS; Hypotheses and Pitfalls.

Authors:  Camille Petillon; Rudolf Hergesheimer; Hervé Puy; Philippe Corcia; Patrick Vourc'h; Christian Andres; Zoubida Karim; Hélène Blasco
Journal:  Front Neurosci       Date:  2019-01-15       Impact factor: 4.677

Review 7.  The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?

Authors:  Rudolf C Hergesheimer; Anna A Chami; Denis Reis de Assis; Patrick Vourc'h; Christian R Andres; Philippe Corcia; Débora Lanznaster; Hélène Blasco
Journal:  Brain       Date:  2019-05-01       Impact factor: 13.501

8.  Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis.

Authors:  Luke McAlary; Steven S Plotkin; Justin J Yerbury; Neil R Cashman
Journal:  Front Mol Neurosci       Date:  2019-11-01       Impact factor: 5.639

9.  Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises.

Authors:  Luke McAlary; Yee Lian Chew; Jeremy Stephen Lum; Nicholas John Geraghty; Justin John Yerbury; Neil R Cashman
Journal:  Front Cell Neurosci       Date:  2020-11-04       Impact factor: 5.505

10.  Clusterin protects neurons against intracellular proteotoxicity.

Authors:  Jenna M Gregory; Daniel R Whiten; Rebecca A Brown; Teresa P Barros; Janet R Kumita; Justin J Yerbury; Sandeep Satapathy; Karina McDade; Colin Smith; Leila M Luheshi; Christopher M Dobson; Mark R Wilson
Journal:  Acta Neuropathol Commun       Date:  2017-11-07       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.